FGF23 and chronic kidney disease: In the current study, we examined the relationship between circulating FGF23 and serum aldosterone levels in CKD patients and in an experimental CKD model, using data from a prospective study in humans, a retrospective study in cats and dogs, and an experimental study in 5/6-nephrectomized (5/6-Nx) mice.